Chemistry Analyzer Piccolo Xpress, CLIA Waived (AMBIS 2247161)
Closed Solicitation Posted
- Solicitation number
- RFQ-NIAID-25-2247161
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Gaithersburg, Maryland 20878, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is seeking to procure two Piccolo Xpress Chemistry Analyzers for its Vaccine Research Center's Vaccine Production Program. These brand-specific analyzers are critical for conducting post-discharge studies in L9LS clinical trials being conducted in Kenya. The solicitation is issued as a Request for Quotes (RFQ) using Simplified Acquisition Procedures under FAR Part 13, with a specific requirement for brand continuity and compatibility with existing laboratory equipment. The evaluation criteria will focus on technical capability to meet requirements, pricing, and delivery performance. Interested vendors must submit quotes through the NIAID electronic Simplified Acquisition Submission System (eSASS) by January 13, 2025, at 4:00 PM EST, with a required delivery timeline of 45 days after receipt of order.
The procurement is classified under NAICS code 334516 for Analytical Laboratory Instrument Manufacturing, with a size standard of 1,000 employees, and does not include a small business set-aside. The place of performance is located at the NIH, NIAID, Vaccine Research Center in Gaithersburg, Maryland, specifically at 9 West Watkins Mill Road. The government intends to award a firm-fixed price purchase order for the two Piccolo Xpress Analyzers (Part # 07P05-01), which are CLIA-waived and designed for portable, accurate laboratory testing. The analyzers must match existing instruments currently in use in both BSL2 and BSL4 environments, ensuring research continuity. Shipping and handling are included, with delivery FOB destination, and the total procurement is expected to be a low-value contract focused on specialized scientific equipment for infectious disease research.
Notice text
2 versions
Update #2 · Latest ·
This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-25-2247161 and the solicitation is issued as a Request for Quotes (RFQ).
This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2025-01 November 12, 2024.
The North American Industry Classification System (NAICS) code for this procurement is 334516, Analytical Laboratory Instrument Manufacturing, with a size standard of 1000 employees. The requirement is being competed with a brand name restriction, and without a small business set-aside.
Project Description:
The NIH, NIAID, Vaccine Research Center (VRC), Vaccine Production Program (VPP), has a current requirement for brand-name Piccolo Express Chemistry Analyzers. These analyzers are needed for the post discharge study in the L9LS clinical trials which are being run in Kenya. It is only important to ensure that the Piccolo Xpress instrument, which are considered simple and low-risk, and are regulated by the Clinical Laboratory Improvement Amendments (CLIA). Very importantly, the new instruments must match current instruments used to perform on earlier study. Due to continuity protocols, as well as compatibility, the requested analyzer brand is required. Currently we have 1 Piccolo in the BSL2 and 4 in the BSL4. The Piccolo Xpress is a portable analyzer that has a small footprint and produces accurate, reliable, and reproducible results. The requested brand is required due to
continuity, compatibility, size requirements. This equipment will allow for continued analysis of samples and in order to maintain continuity in research
The National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center, Vaccine Production Program (VPP) has a requirement for the following Brand Name Supplies:
Description of need:
- Chemistry Analyzer – Piccolo Xpress Analyzer, Part # 07P05-01, Qty - 2
- Shipping & Handling, Qty - 1
Delivery: 45 days ARO
Place of Performance: NIH, NIAID, VRC, VPP, 9 West Watkins Mill Road, Gaithersburg, MD 20878, United States. FOB: Destination
The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following: technical capability to meet the requirements, price, and delivery.
By submitting a quote in response to this solicitation, vendor is accepting the following terms and conditions:
The following FAR provisions apply to this acquisition:
FAR 52.212-1 Instructions to Offerors Commercial Items (SEP 2023)
FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (MAY 2024)
FAR 52.204-7 System for Award Management (OCT 2018)
(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)
FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017)
FAR 52.204–26 Covered Telecommunications Equipment or Services-Representation
(OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26
The following FAR contract clauses apply to this acquisition:
FAR 52-212-4 Contract Terms and Conditions Commercial Items (NOV 2023)
FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (NOV 2024)
*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.
FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023)
FAR 52.204-13 System for Award Management Maintenance (OCT 2018)
FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021)
HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (DEC 2015)
52.252-2 -- Clauses Incorporated by Reference. (FEB 1998)
This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm
By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).
Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.
Submission shall be received not later than Friday, January 17, 2025 @ 4:00 PM EST
All quotations and required documents must be submitted via the NIAID electronic Simplified Acquisition Submission System (eSASS) website at https://esass.nih.gov. All vendors must register in the eSASS system to submit a quotation. Instructions on how to register / submit quotes are included on the website. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responsible sources may submit an offer that will be considered by this Agency.
Update #1 ·
This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-25-2247161 and the solicitation is issued as a Request for Quotes (RFQ).
This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2025-01 November 12, 2024.
The North American Industry Classification System (NAICS) code for this procurement is 334516, Analytical Laboratory Instrument Manufacturing, with a size standard of 1000 employees. The requirement is being competed with a brand name restriction, and without a small business set-aside.
Project Description:
The NIH, NIAID, Vaccine Research Center (VRC), Vaccine Production Program (VPP), has a current requirement for brand-name Piccolo Express Chemistry Analyzers. These analyzers are needed for the post discharge study in the L9LS clinical trials which are being run in Kenya. It is only important to ensure that the Piccolo Xpress instrument, which are considered simple and low-risk, and are regulated by the Clinical Laboratory Improvement Amendments (CLIA). Very importantly, the new instruments must match current instruments used to perform on earlier study. Due to continuity protocols, as well as compatibility, the requested analyzer brand is required. Currently we have 1 Piccolo in the BSL2 and 4 in the BSL4. The Piccolo Xpress is a portable analyzer that has a small footprint and produces accurate, reliable, and reproducible results. The requested brand is required due to
continuity, compatibility, size requirements. This equipment will allow for continued analysis of samples and in order to maintain continuity in research
The National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center, Vaccine Production Program (VPP) has a requirement for the following Brand Name Supplies:
Description of need:
- Chemistry Analyzer – Piccolo Xpress Analyzer, Part # 07P05-01, Qty - 2
- Shipping & Handling, Qty - 1
Delivery: 45 days ARO
Place of Performance: NIH, NIAID, VRC, VPP, 9 West Watkins Mill Road, Gaithersburg, MD 20878, United States. FOB: Destination
The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following: technical capability to meet the requirements, price, and delivery.
By submitting a quote in response to this solicitation, vendor is accepting the following terms and conditions:
The following FAR provisions apply to this acquisition:
FAR 52.212-1 Instructions to Offerors Commercial Items (SEP 2023)
FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (MAY 2024)
FAR 52.204-7 System for Award Management (OCT 2018)
(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)
FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017)
FAR 52.204–26 Covered Telecommunications Equipment or Services-Representation
(OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26
The following FAR contract clauses apply to this acquisition:
FAR 52-212-4 Contract Terms and Conditions Commercial Items (NOV 2023)
FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (NOV 2024)
*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.
FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023)
FAR 52.204-13 System for Award Management Maintenance (OCT 2018)
FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021)
HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (DEC 2015)
52.252-2 -- Clauses Incorporated by Reference. (FEB 1998)
This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm
By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).
Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.
Submission shall be received not later than Monday, January 13, 2025 @ 4:00 PM EST
All quotations and required documents must be submitted via the NIAID electronic Simplified Acquisition Submission System (eSASS) website at https://esass.nih.gov. All vendors must register in the eSASS system to submit a quotation. Instructions on how to register / submit quotes are included on the website. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responsible sources may submit an offer that will be considered by this Agency.
Files
| File | Type | Posted |
|---|---|---|
| RFQ-NIAID-25-2247161_Specifications.pdf | ||
| Terms and Conditions_FAR 52.212-5_Nov 2024.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity